Novonordisk.com recives any estimated n/a unique visitors and n/a unique page views per day. Revenue gained from these much visits may be n/a per day from various advertising sources. The estimated worth of site is n/a.
- Website Age
n/a
- Alexa Rank no-data
- Country
Netherlands
- IP Address
52.166.181.85
google ads
HTML SIZE INFORMATION
novonordisk.com has a website text/code ratio of 7.09 %. Search engine crawlers tend to not pick up pages with inadequate content.
IMPORTANT HTML TAGS AND COUNTS
Titles
H1
No |
Text |
1 |
438 we offer0 job opportunities |
H2
No |
Text |
1 |
Our response to covıd-19 |
2 |
Our research areas |
3 |
Turning scientific ideas into medicines |
4 |
Making our medicines accessible and affordable |
5 |
Preventing the rise of type 2 diabetes |
H3
No |
Text |
1 |
ımportant safety information about colour change for fiasp® flextouch® and fiasp® penfill® |
H4
No |
Text |
1 |
Our commitment todefeat diabetes |
2 |
Who we are |
3 |
Novo nordisk websites |
4 |
Novo nordisk worldwide |
5 |
Shareholder ınformation |
6 |
Annual reporting |
7 |
Contact quick links |
H5
Text Styling
- STRONG1
- B0
- EM0
- I0
- U0
- CITE0
STRONG
LINK ANALYSIS
Total Link Count: 147
Internal Link Count
: 133
No |
Text |
Type |
1 |
- |
empty |
2 |
- |
empty |
3 |
Back |
text |
4 |
Patients |
text |
5 |
Patients |
text |
6 |
Type 1 diabetes |
text |
7 |
Type 1 diabetes |
text |
8 |
Gestational diabetes |
text |
9 |
Gestational diabetes |
text |
10 |
Diabetes pens and needles support |
text |
11 |
Diabetes pens and needles support |
text |
12 |
Haemophilia |
text |
13 |
Growth disorders and growth hormone pens |
text |
14 |
Growth disorders and growth hormone pens |
text |
15 |
Disease experience expert panel (DEEP) |
text |
16 |
Research & Development |
text |
17 |
Research & Development |
text |
18 |
Science & innovation |
text |
19 |
Science & innovation |
text |
20 |
Our scientific approach |
text |
21 |
Stem cell research |
text |
22 |
R&D facts & figures |
text |
23 |
Global R&D centres |
text |
24 |
Publications |
text |
25 |
Our therapy areas |
text |
26 |
Our therapy areas |
text |
27 |
Type 1 diabetes |
text |
28 |
Type 2 diabetes |
text |
29 |
Obesity |
text |
30 |
Atherosclerosis |
text |
31 |
NASH |
text |
32 |
Haemophilia |
text |
33 |
Growth disorders |
text |
34 |
Partner with us |
text |
35 |
Partnering opportunities |
text |
36 |
Events & meetings |
text |
37 |
Contact us |
text |
38 |
Open innovation |
text |
39 |
Compound sharing |
text |
40 |
Innovation Challenges |
text |
41 |
Future science |
text |
42 |
Pipeline |
text |
43 |
Bioethics |
text |
44 |
Bioethics |
text |
45 |
Animal ethics |
text |
46 |
Clinical trial ethics |
text |
47 |
Human biosample ethics |
text |
48 |
Stem cell ethics |
text |
49 |
Gene technology ethics |
text |
50 |
Sustainable business |
text |
External Link Count
: 14
No |
Text |
Type |
1 |
Type 2 diabetes |
text |
2 |
Type 2 diabetes |
text |
3 |
Obesity |
text |
4 |
Obesity |
text |
5 |
Partic****ting in our clinical trials |
text |
6 |
Clinical trials |
text |
7 |
Please visit NovoCare |
text |
8 |
- |
image |
9 |
- |
image |
10 |
- |
image |
11 |
- |
image |
12 |
- |
image |
13 |
Novo Nordisk in the USA |
image |
14 |
Novo Nordisk in Denmark |
image |
Nofollow Link Count
: 0
Title Link Count
: 0
WEBSITE SERVER INFORMATION
- Service Provider (ISP)
- Microsoft Corporation
- Hosted IP Address
- 52.166.181.85
- Hosted Country
Netherlands
- Host Region
- North Holland , Amsterdam
- Latitude and Longitude
- 52.3667 : 4.9
WEBSITES USING THE SAME IP ADDRESS